Theralase Technologies Inc (CVE:TLT) (OTCMKTS:TLTFF)laser technology used in eliminating pain and destroying cancer. Theralase technology is safe and effective in eliminating pain, reducing inflammation and accelerating tissue regeneration of numerous nerve, muscle and joint conditions. Theralase is actively developing patented technology that is able to target and destroy cancers, bacteria and viruses when light activated.
Theralase Technologies Inc
CVE:TLT ISIN:CA88337V1004
News
Theralase Technologies Inc. (CVE:TLT) (OTCMKTS:TLTFF) announced today that in preclinical animal testing, performed at Princess Margaret Cancer Centre, University Health Network ("UHN"), it has discovered that its lead Photo Dynamic Compound (PDC), intended for the destruction of cancer, has demonstrated an ability to render animals immune to repeated exposures of the same cancer.
###
3,742 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 17) (Since Published: 3742)